RecruitingPhase 3NCT07662044
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Birmingham, AL · Daphne, AL · +25 more sites